ArticleAmerican journal of hematology2022

Improved outcomes among newly diagnosed patients with FMS-like tyrosine kinase 3 internal tandem duplication mutated acute myeloid leukemia treated with contemporary therapy: Revisiting the European LeukemiaNet adverse risk classification.

Patrick K Reville et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.